Cultivate Biologics Logo

About Us

Who We Are

Cultivate Biologics specializes in developing botanical drugs tailored to address inflammatory and neurological disorders through full spectrum cannabinoid options. Our pioneering approach involves a novel process that renders botanicals suitable for FDA-approved drug applications. Leveraging our advanced plant breeding program and precise replication of complex plant extracts, we unlock the unexplored therapeutic potential of botanicals for the benefit of human and animal health.

Our commitment to scientific excellence is exemplified through extensive clinical research, building collaborations with esteemed academic institutions, and advancing botanical drug development. With a focus on full-spectrum cannabinoid extracts, we lead the charge in developing innovative and effective therapies.

At Cultivate Biologics, our mission is clear: to cultivate wellness through nature’s precision. Join us in this transformative journey as we redefine possibilities in health and well-being.

Our Infrastructure

Cultivate is dedicated to finding botanical-based drug solutions through a tightly controlled cultivation and development process that brings pharmaceutical-grade precision to our botanical-based drug development pipeline.

Through our own testing and research capabilities, along with strategic partnerships with leading research institutions, Cultivate develops hemp-based extracts with unique, consistent plant characteristics that ensure efficacious and safe botanical-based health solutions. 

Alongside our own hemp-based research, we also offer research partnerships to other organizations pursuing drug development using a variety of botanicals. In these partnerships, we offer the same cultivation expertise, lab testing, and precise development pipeline that has allowed Cultivate to pioneer new research for both human and animal health.

Founded on a Love of Science and a Passion to Improve Human and Animal Health

Christian Kjaer

Christian Kjaer

Board Chair & CEO

Christian Kjaer, Board Chair & CEO, brings a wealth of executive experience to Cultivate Biologics. A former senior executive at IDEXX Laboratories, Christian served as President of OPTI Medical Systems and held the positions of VP and GM of the Water Division, as well as VP and GM of the South Asia/Middle East/Africa Region. His extensive leadership extends beyond borders, as he has previously held CEO positions in prominent European tech companies.

In addition to his role at Cultivate Biologics, Christian serves as the Board Chair and CEO of ElleVet Sciences and TevElle Pharmaceuticals. He holds a Master of Business from the prestigious Copenhagen Business School, a testament to his academic dedication and business acumen. Christian’s multifaceted expertise and strategic vision guide Cultivate Biologics towards a future of innovative and impactful advancements in the field of cannabinoid research.


Joseph Wakshlag

Dr. Joseph Wakshlag, DVM, PhD, DACVN, DACVSMR

Chief Scientific Officer

Dr. Joseph Wakshlag, DVM, PhD, DACVN, DACVSMR, serves as the Chief Scientific Officer at Cultivate Biologics. Currently a distinguished professor at the Cornell College of Veterinary Medicine, he also holds the pivotal role of Chief Veterinary Medical Officer at ElleVet Sciences, a renowned leader in veterinary hemp products. With a rich background, Dr. Wakshlag is a charter member of the American College of Sports Medicine and Rehabilitation, highlighting his dedication to the interdisciplinary field of sports medicine.

His significant contributions to the scientific community include authoring 14 publications, encompassing a diverse range of topics in full spectrum CBD/CBDA hemp use. Dr. Wakshlag has conducted pioneering clinical trials examining the efficacy of hemp in conditions such as osteoarthritis, acute post-surgical pain, and atopic dermatitis in dogs. His research extends beyond species boundaries, delving into cross-species pharmacokinetics in horses, cats, dogs, and birds.

Dr. Wakshlag’s multifaceted expertise positions him as a key figure in advancing the understanding of cannabinoid therapeutics, contributing to the growth and success of Cultivate Biologics in the realm of innovative health solutions.